Norris Medicines Q2 Results

  • BSE: 524414
  • NSE: -
  • ISIN: INE744C01029
  • Sector: Biotechnology & Drugs
BSE
18.47-0.97 (-4.99%)
Volume2.49 K
Updated: Tue 26 Nov, 2024 | 11:09:59
NSE
This stock is not traded on NSE
Today: 18.47
19.05
52-Wk: 10.70
27.74

Q2 Results Highlights

  • Total Income
    ₹1.27 Cr.
    (74.98%)
  • Operating Profit
    ₹-0.28 Cr.
    (-5.39%)
  • Profit After Tax
    ₹-0.36 Cr.
    (-1.39%)
  • Operating Margin
    -21.88%
    (43.34%)
Note: Comparison is on YoY basis

Quarterly - Norris Medicines Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 22QoQ CompSep 23YoY Comp
Total Revenue 1.270.95-%2.56-%
Selling/ General/ Admin Expenses Total 0.290.44-%0.48-%
Depreciation/ Amortization 0.130.15-%0.14-%
Total Operating Expense 1.551.30-%2.95-%
Operating Income -0.28-0.35-%-0.39-%
Net Income Before Taxes -0.36-0.44-%-0.48-%
Net Income -0.36-0.44-%-0.48-%
Diluted Normalized EPS -0.36-0.44-%-0.48-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts